EPI-506

· ESSA Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EPI-506, covering 2018-03-01 to 2018-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]

See pricing